A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B
|4||Active, not recruiting||
A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
† Study has passed its completion date and status has not been verified in more than two years.